FIIs Boost Stakes in GRM Overseas, Torrent Pharma, Kovai Medical Amidst Market Sell-off

• Despite significant FII selling in the Indian market (Rs 217.06 billion in Jan 2026 alone), FIIs increased their stake in select stocks during Q4 2025.
• GRM Overseas, a basmati rice and packaged food company, saw FII stake rise from 1.89% to 3.36%. The company reported strong Q2 FY26 revenue growth of 16.2% and net profit jump of 60.5%.
• Torrent Pharmaceuticals, focusing on cardio, CNS, and gastro segments, experienced an FII stake increase from 15.92% to 16.13%. Its Q2 FY26 net profit grew from Rs 453 crore to Rs 591 crore.
• Kovai Medical Center and Hospital, a multi-specialty hospital in Tamil Nadu, saw FII stake slightly increase from 1.25% to 1.31%. The hospital plans significant expansion with new beds and facilities.
• Investors should not solely rely on FII buying for investment decisions; understanding the underlying reasons and company fundamentals is crucial, as FII sentiment can change rapidly.

Why It Matters: FIIs are selectively increasing stakes in strong companies like GRM Overseas, Torrent Pharma, and Kovai Medical despite broader market selling.